Is AbbVie a good dividend stock to buy right now?
With a dividend program already on solid footing and new drugs driving growth, AbbVie looks like a great dividend stock to buy right now. When our award-winning analyst team has a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*
Is AbbVie a bad news buy?
The U.S. Food and Drug Administration (FDA) has placed additional warnings on the labels for JAK inhibitors marketed by AbbVie (NYSE ... or could more bad news be on the way?
Should you buy abbv stock?
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks ... Investors should also note AbbVie's current ...
Is abbv a good stock?
Despite hiking its payout, AbbVie was able to meet its obligation using just 42% of the free cash flow its lucrative pharmaceutical operations generated over the past year. With a dividend program already on solid footing and new drugs driving growth, AbbVie looks like a great dividend stock to buy right now.
See more
Is it a good time to buy AbbVie?
AbbVie Inc. may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of ABBV, demonstrate its potential to outperform the market. It currently has a Growth Score of A.
What is AbbVie target price?
Stock Price TargetHigh$200.00Low$135.00Average$163.81Current Price$153.23
How much does AbbVie pay per share?
(NYSE: ABBV) today declared a quarterly cash dividend of $1.41 per share. The cash dividend is payable May 16, 2022 to stockholders of record at the close of business on April 15, 2022. Since the company's inception in 2013, AbbVie has increased its dividend by more than 250 percent.
What is AbbVie dividend growth rate?
During the past 12 months, AbbVie's average Dividends Per Share Growth Rate was 9.70% per year. During the past 3 years, the average Dividends Per Share Growth Rate was 13.10% per year. During the past 5 years, the average Dividends Per Share Growth Rate was 19.20% per year.
How high will AbbVie go?
The 20 analysts offering 12-month price forecasts for Abbvie Inc have a median target of 160.00, with a high estimate of 200.00 and a low estimate of 135.00. The median estimate represents a +7.77% increase from the last price of 148.47.
Is AbbVie stock a buy?
Still worth buying Second, AbbVie looks attractively valued at the moment with a forward price-to-earnings (P/E) ratio of 10.9, compared to an average of 12.8 for the pharmaceutical industry. Third, AbbVie is an excellent stock for dividend-seeking investors.
Which stock has the highest dividend?
9 highest dividend-paying stocks in the S&P 500:AT&T Inc. (T)Williams Cos. Inc. (WMB)Devon Energy Corp. (DVN)Oneok Inc. (OKE)Simon Property Group Inc. (SPG)Kinder Morgan Inc. (KMI)Vornado Realty Trust (VNO)Altria Group Inc. (MO)More items...•
How often does AbbVie stock pay dividends?
Dividend Summary There are typically 4 dividends per year (excluding specials), and the dividend cover is approximately 2.1.
What months does AbbVie pay dividends?
AbbVie's upcoming ex-dividend date is on Jul 13, 2022. AbbVie shareholders who own ABBV stock before this date will receive AbbVie's next dividend payment of $1.41 per share on Aug 14, 2022.
Is AbbVie a good dividend stock?
AbbVie is a Dividend Aristocrat with a juicy dividend yield but will soon face declining sales of its top drug. Pfizer's dividend yield isn't as high as AbbVie's, but its overall growth prospects look better.
Will AbbVie increase dividend in 2021?
(NYSE: ABBV) today declared a quarterly cash dividend of $1.30 per share. The cash dividend is payable August 16, 2021 to stockholders of record at the close of business on July 15, 2021. Since the company's inception in 2013, AbbVie has increased its dividend by 225 percent.
Are AbbVie dividends qualified?
The AbbVie dividend (as an Abbott Labs spin off) has increased for 50 consecutive years; qualifying the company as a Dividend King.
Should I buy or sell AbbVie stock right now?
16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for AbbVie in the last year. There are currently 1 sell rat...
What is AbbVie's stock price forecast for 2022?
16 Wall Street analysts have issued 12 month price targets for AbbVie's stock. Their ABBV stock forecasts range from $135.00 to $200.00. On average...
How has AbbVie's stock price performed in 2022?
AbbVie's stock was trading at $135.40 at the beginning of the year. Since then, ABBV stock has increased by 5.8% and is now trading at $143.20. Vi...
When is AbbVie's next earnings date?
AbbVie is scheduled to release its next quarterly earnings announcement on Friday, July 29th 2022. View our earnings forecast for AbbVie .
How were AbbVie's earnings last quarter?
AbbVie Inc. (NYSE:ABBV) posted its quarterly earnings results on Friday, April, 29th. The company reported $3.16 earnings per share (EPS) for the q...
How often does AbbVie pay dividends? What is the dividend yield for AbbVie?
AbbVie announced a quarterly dividend on Thursday, February 17th. Shareholders of record on Friday, April 15th will be given a dividend of $1.41 pe...
Is AbbVie a good dividend stock?
AbbVie(NYSE:ABBV) pays an annual dividend of $5.64 per share and currently has a dividend yield of 3.94%. AbbVie has been increasing its dividend f...
What guidance has AbbVie issued on next quarter's earnings?
AbbVie updated its FY 2022 earnings guidance on Monday, May, 9th. The company provided earnings per share (EPS) guidance of $13.92-$14.12 for the p...
Who are AbbVie's key executives?
AbbVie's management team includes the following people: Mr. Richard A. Gonzalez , Chairman & CEO (Age 68, Pay $7.42M) ( LinkedIn Profile ) Mr. R...
How much does Abbvie make?
Is Abbvie a dividend payer?
AbbVie has a market capitalization of $208.04 billion and generates $45.80 billion in revenue each year. The company earns $4.62 billion in net income (profit) each year or $10.56 on an earnings per share basis.
AbbVie Is a Top Pick in an Uncertain Market
ABBV has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. AbbVie has been increasing its dividend for 49 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of AbbVie is 49.24%.
3 Rock-Solid Stocks That Are Money Machines
AbbVie (NYSE: ABBV), on the other hand, has been on a tear, gaining over 20% in the last six months, and over 6% year to date. Investors recognize that AbbVie can be a rock-solid dividend stalwart in their portfolios during uncertain times. Americans are paying higher prices, and the current inflation rate is unsustainable.
When did Abbvie buy Allergan?
These big companies should continue generating strong cash flow and paying great dividends for years to come.
Is ZacksTrade a separate company?
It announced a definitive agreement to buy Allergan on Jun 24, 2019. AbbVie paid Allergan a price of $120.30 in cash and 0.8660 AbbVie shares per Allergan share. The deal closed in May 2020.
Abbott (ABT) COVID Testing Sales Surge, FX Headwind Stays
ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating indiv idual securities.
Health Tech in 2022
Abbott (ABT) registers strong growth in its more consumer-facing businesses like nutrition, established pharmaceuticals and diabetes care.
